These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 20689764)
1. Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model. Meunier L; Puiffe ML; Le Page C; Filali-Mouhim A; Chevrette M; Tonin PN; Provencher DM; Mes-Masson AM Transl Oncol; 2010 Aug; 3(4):230-8. PubMed ID: 20689764 [TBL] [Abstract][Full Text] [Related]
2. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Puiffe ML; Le Page C; Filali-Mouhim A; Zietarska M; Ouellet V; Tonin PN; Chevrette M; Provencher DM; Mes-Masson AM Neoplasia; 2007 Oct; 9(10):820-9. PubMed ID: 17971902 [TBL] [Abstract][Full Text] [Related]
3. The ascites N-glycome of epithelial ovarian cancer patients. Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862 [TBL] [Abstract][Full Text] [Related]
4. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Zietarska M; Maugard CM; Filali-Mouhim A; Alam-Fahmy M; Tonin PN; Provencher DM; Mes-Masson AM Mol Carcinog; 2007 Oct; 46(10):872-85. PubMed ID: 17455221 [TBL] [Abstract][Full Text] [Related]
5. Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines. Cody NA; Zietarska M; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN BMC Med Genomics; 2008 Aug; 1():34. PubMed ID: 18687136 [TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018 [TBL] [Abstract][Full Text] [Related]
7. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer. Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289 [TBL] [Abstract][Full Text] [Related]
8. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423 [TBL] [Abstract][Full Text] [Related]
10. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856 [TBL] [Abstract][Full Text] [Related]
11. Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites. Manning AP; Mes-Masson AM; Seymour RJ; Tetrault M; Provencher DM; Tonin PN Mol Carcinog; 1999 Mar; 24(3):218-25. PubMed ID: 10204806 [TBL] [Abstract][Full Text] [Related]
12. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer. Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012 [TBL] [Abstract][Full Text] [Related]
13. [Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens]. Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):834-9. PubMed ID: 18476518 [TBL] [Abstract][Full Text] [Related]
14. Visfatin derived from ascites promotes ovarian cancer cell migration through Rho/ROCK signaling-mediated actin polymerization. Li Y; Li X; Liu KR; Zhang JN; Liu Y; Zhu Y Eur J Cancer Prev; 2015 May; 24(3):231-9. PubMed ID: 25055182 [TBL] [Abstract][Full Text] [Related]
15. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells. Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050 [TBL] [Abstract][Full Text] [Related]
16. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384 [TBL] [Abstract][Full Text] [Related]
18. High expression of LAMP1 as a prognostic marker in patients with epithelial ovarian cancer. Xu Y; Cao X; Zhang S; Zhang Y; Shen Z Int J Clin Exp Pathol; 2017; 10(8):9104-9111. PubMed ID: 31966783 [TBL] [Abstract][Full Text] [Related]
19. Chromatin target of protein arginine methyltransferase regulates invasion, chemoresistance, and stemness in epithelial ovarian cancer. Feng X; Li L; Wang L; Luo S; Bai X Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910850 [TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Runnebaum IB; Brüning A Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]